ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc (ACAD)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US
In this article, we take a look at the Best Drug and Alcohol Rehab Centers in Each of the 30 Biggest Cities in the US.
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
In this article, we will take a look at the 10 stocks receiving a massive vote of approval from Wall Street analysts.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.
Billionaire Stan Druckenmiller's Small-Cap Stock Picks
In this piece, we will take a look at billionaire Stanley Druckenmiller's small-cap stock picks. If you want to skip our introduction to Mr.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen and welcome to ACADIA Pharmaceuticals’ Second Quarter 2023 Financial Results Conference Call. My name is [Jeda] and I'll be your coordinator for today.
Hedge Fund and Insider Trading News: Carl Icahn, Steve Cohen, Cliff Asness, Mudrick Capital, Third Point LLC, Lodbrok Capital, Renaissancere Holdings Ltd (RNR), Southwest Gas Holdings, Inc. (SWX), and More
An American fund manager that rose to prominence during Wall Street’s meme stock trading frenzy is considering a plan to raise £300 million by listing an investment company on the London market that...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to ACADIA Pharmaceuticals’ First Quarter 2023 Financial Results Conference Call.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. And welcome to ACADIA Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
